Crossmark

Lenalidomide enhances the function of chimeric antigen receptor T cells against the epidermal growth factor receptor variant III by enhancing immune synapses

Crossref DOI link: https://doi.org/10.1038/cgt.2015.47

Published Online: 2015-10-09

Published Print: 2015-10

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Kuramitsu, S

Ohno, M

Ohka, F

Shiina, S

Yamamichi, A

Kato, A

Tanahashi, K

Motomura, K

Kondo, G

Kurimoto, M

Senga, T

Wakabayashi, T

Natsume, A
License Information

Text and Data Mining valid from 2015-10-01

Version of Record valid from 2015-10-01
More Information

Article History

Received: 14 March 2015

Revised: 14 August 2015

Accepted: 15 August 2015

First Online: 9 October 2015

Competing interests

: The authors declare no conflict of interest.

Document is current

Any future updates will be listed below